Olympus America

Press Center

OLYMPUS AND PSS WORLD MEDICAL SIGN DISTRIBUTION AGREEMENT



CENTER VALLEY, PA, November 6, 2006 - Olympus America Inc. and PSS World Medical Inc. (NasdaqGS:PSSI) (Jacksonville, FL.) have signed a three-year distribution agreement. Under the terms of the agreement, PSS is appointed the exclusive distributor of select Olympus® AU chemistry-immuno analyzers to physician office laboratories (POL) throughout the United States. The distribution agreement includes new and refurbished AU 400e, AU 640e and AU 2700 analyzers. Olympus will also provide instrument service and technical telephone support to all PSS World Medical customers purchasing AU-series analyzers in the U.S.

“The Olympus AU chemistry-immuno analyzers represent a key component of our comprehensive product offering for physician office laboratories ,” said John F. Sasen, Chief Marketing Officer for PSS World Medical, Inc. “We are pleased to partner with Olympus, and look forward to leveraging our industry-leading sales force, innovative marketing programs and solutions-focused services to better serve the diagnostic and clinical care needs of physicians,” concluded Mr. Sasen.

“The distribution agreement gives Olympus entrée into this crucial market on behalf of our customers and their patients,” added Michael Argentieri, Vice President of Sales and Marketing for Olympus America Inc.'s Diagnostic Systems Group. “This agreement will allow PSS and Olympus to work together to reach more healthcare organizations and professionals who could benefit by incorporating AU analyzers into their practices.”

About PSS World Medical, Inc.
PSS World Medical, Inc. is a national distributor of medical products to physicians and elder care providers through its two business units. Since its inception in 1983, PSS has become a leader in the two market segments that it serves with a focused market approach to customer services, a consultative sales force, strategic acquisitions, strong arrangements with product manufacturers and a unique culture of performance.


About Olympus Diagnostic Systems Group
Olympus Diagnostic Systems provides innovative solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks, physician offices and pharmaceutical labs. Olympus offers the broadest standardized line of random access chemistry-immuno analyzers, along with lab automation systems, blood bank analyzers and reagents. Olympus solutions save laboratories time, maximize productivity, and deliver fast, reliable results.

About Olympus
Olympus is a precision technology leader, designing and delivering imaging solutions in healthcare, life science and photography. Olympus works collaboratively with its customers and its parent company, Tokyo-based Olympus Corporation, to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:

  • Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
  • Advanced clinical and research microscopes;
  • Lab automation systems, chemistry-immuno and blood bank analyzers and reagents; and
  • Digital and film cameras, and digital voice recorders.

In the U. S. and Canada, Olympus serves healthcare, scientific and commercial laboratory markets with integrated product solutions and financial, educational and consulting services that help customers efficiently, reliably, safely, and easily achieve superior results. Olympus is the leader in gastrointestinal endoscopy and clinical and educational microscopes. The company’s consumer electronics business spans North and South America. For more information, visit www.olympusamerica.com.